DK0573462T3 - Fremgangsmåde til fremhævning af fordybninger i tabletter - Google Patents

Fremgangsmåde til fremhævning af fordybninger i tabletter

Info

Publication number
DK0573462T3
DK0573462T3 DK92904760.3T DK92904760T DK0573462T3 DK 0573462 T3 DK0573462 T3 DK 0573462T3 DK 92904760 T DK92904760 T DK 92904760T DK 0573462 T3 DK0573462 T3 DK 0573462T3
Authority
DK
Denmark
Prior art keywords
tablets
highlighting
indentations
solvent
filling material
Prior art date
Application number
DK92904760.3T
Other languages
Danish (da)
English (en)
Inventor
Paul M V Gilis
Conde Valentin F V De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0573462T3 publication Critical patent/DK0573462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
  • Color Printing (AREA)
DK92904760.3T 1991-02-27 1992-02-14 Fremgangsmåde til fremhævning af fordybninger i tabletter DK0573462T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200417 1991-02-27

Publications (1)

Publication Number Publication Date
DK0573462T3 true DK0573462T3 (da) 1996-11-11

Family

ID=8207528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904760.3T DK0573462T3 (da) 1991-02-27 1992-02-14 Fremgangsmåde til fremhævning af fordybninger i tabletter

Country Status (16)

Country Link
US (1) US5405642A (de)
EP (2) EP0573462B1 (de)
JP (1) JP3237758B2 (de)
AT (1) ATE143259T1 (de)
AU (1) AU1260392A (de)
CA (1) CA2104096C (de)
DE (1) DE69214130T2 (de)
DK (1) DK0573462T3 (de)
ES (1) ES2094902T3 (de)
GR (1) GR3021929T3 (de)
IE (1) IE75729B1 (de)
MX (1) MX9200831A (de)
NZ (1) NZ241613A (de)
TW (1) TW201697B (de)
WO (1) WO1992015288A1 (de)
ZA (1) ZA921428B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
DK0927556T3 (da) 1997-09-23 2000-11-20 Akzo Nobel Nv Coatede dosisenheder
US6685961B1 (en) 2000-10-24 2004-02-03 Banner Pharmacaps, Inc. Colored gelatin-based formulations and method
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
BR0212950A (pt) * 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
AU2003247638B2 (en) * 2002-06-26 2009-11-26 Mars, Incorporated Edible inks for ink-jet printing on edible substrates
US7029112B2 (en) 2002-08-05 2006-04-18 Mars, Incorporated Ink-jet printing on surface modified edibles and products made
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ATE396237T1 (de) * 2003-03-07 2008-06-15 Mars Inc Wässrige tinten zum bedrucken von süssware
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
NZ551340A (en) * 2004-04-22 2010-10-29 Boehringer Ingelheim Int Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
CA2576812A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
EP1858515A2 (de) * 2005-03-04 2007-11-28 Boehringer Ingelheim International Gmbh Pharmazeutische zusammensetzungen zur behandlung und/oder vorbeugung von mit angstzuständen verbundenen erkrankungen
JP2008538741A (ja) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 鬱病の治療用及び／又は予防用の医薬組成物
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP1904182A2 (de) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Verfahren zur behandlung von drogenmissbrauch mit flibanserin
WO2006125041A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunctions due to medical conditions
CA2608363A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
WO2007035926A2 (en) * 2005-09-22 2007-03-29 Bpsi Holdings, Inc. Method for printing on tablets and etched printing plate used therein
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
PT2021006E (pt) * 2006-05-09 2015-11-12 Sprout Pharmaceuticals Inc Uso de flibanserina para o tratamento de distúrbios de desejo sexual pós-menopausa
US20090312242A1 (en) * 2006-06-30 2009-12-17 Ramiro Castro Flibanserin for the treatment of urinary incontinence and related diseases
JP2009543839A (ja) * 2006-07-14 2009-12-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 女性の性的障害を治療するためのフリバンセリンの使用
WO2008019996A2 (en) * 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
KR20090045945A (ko) * 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 제어 방출 시스템 및 이의 제조방법
PE20091188A1 (es) * 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US3436453A (en) * 1963-06-14 1969-04-01 American Cyanamid Co Surface dyed edible gelatin capsule with pigment marking
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
IN158328B (de) * 1981-03-09 1986-10-18 Ici Plc
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
JPS58192819A (ja) * 1982-05-04 1983-11-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤の製法
KR840000624A (ko) * 1982-06-02 1984-02-25 원본미기재 부식억제 페인트 조성물
DE3373624D1 (en) * 1982-06-10 1987-10-22 Ici Plc Manufacture of highlighted intagliated articles
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
FR2548675B1 (fr) * 1983-07-06 1987-01-09 Seppic Sa Compositions filmogenes pour enrobage des formes solides de produits pharmaceutiques ou alimentaires et produits obtenus revetus desdites compositions
US5006362A (en) * 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet

Also Published As

Publication number Publication date
CA2104096A1 (en) 1992-08-28
TW201697B (de) 1993-03-11
AU1260392A (en) 1992-10-06
EP0573462B1 (de) 1996-09-25
MX9200831A (es) 1992-08-01
US5405642A (en) 1995-04-11
JPH06504935A (ja) 1994-06-09
EP0501553A1 (de) 1992-09-02
CA2104096C (en) 2003-06-10
ES2094902T3 (es) 1997-02-01
IE75729B1 (en) 1997-09-24
DE69214130T2 (de) 1997-02-06
EP0573462A1 (de) 1993-12-15
ATE143259T1 (de) 1996-10-15
DE69214130D1 (de) 1996-10-31
IE920611A1 (en) 1992-09-09
ZA921428B (en) 1993-08-26
NZ241613A (en) 1993-06-25
WO1992015288A1 (en) 1992-09-17
JP3237758B2 (ja) 2001-12-10
GR3021929T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
DK0573462T3 (da) Fremgangsmåde til fremhævning af fordybninger i tabletter
DE69012545D1 (de) Farbauftraggerät.
DE69113378D1 (de) Anbringen eines grundierungsmittels.
DE68912785D1 (de) Farbbeschichteter artikel.
DE69201797D1 (de) Strukturierter träger und verfahren zu seiner herstellung.
DE69105078D1 (de) Beschichtungszusammensetzung und damit beschichteter Kunststoffgegenstand.
DE69005926D1 (de) Verfahren zum Beschichten von Titandioxidpigmenten.
DE69011151D1 (de) Ultraviolettunterdrückte Lichtquelle, dafür verwendeter Beschichtungsstoff und Verfahren zu seiner Herstellung.
DE69429088D1 (de) Farbspritzanlage
DE69103218D1 (de) Farbspritzanlage mit kontrolliertem Durchfluss.
DE69201489D1 (de) Beschichtungsverfahren.
FI903063A0 (fi) Bestrykningsanordning.
DE69203574D1 (de) Beschichtungszusammensetzung.
DK0738309T3 (da) Optisk klar, hydrofob overtrækssammensætning
NO913110D0 (no) Beleggmateriale.
DE69214249D1 (de) Polypropylenharz-zusammensetzung, verfahren zur beschichtung von daraus hergestellten geformten gegenständen und so beschichtete geformte gegenstände
DE69124851D1 (de) Zusammensetzungen zum Beschichten von Glasbehältern
DE69005577D1 (de) Farbsprühvorrichtung.
DE69106359D1 (de) Verschmutzungsverhindernde überzugsmassen.
DE69204411D1 (de) Überzugszusammensetzung.
DE69101381D1 (de) Einrichtung zum anlegen von prothesen.
DE69003621D1 (de) Farbspritzanlage mit kontrolliertem durchfluss.
DE69200496D1 (de) Zusammensetzung zur Entfernung von Polymerüberzügen.
IT9047538A0 (it) Prodotto rivestito e metodo per rivestirlo.
DE59100238D1 (de) Verfahren zum beschichten von schaufeln.